Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00035022
Status:
COMPLETED
Last Update Posted:
2006-01-13
First Post:
2002-05-02
Brief Title:
Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas
Sponsor:
Organization:
BioCryst Pharmaceuticals